Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (202)

2024

  1. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

    Joint Bone Spine, Vol. 91, Núm. 2

  2. Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

    The Journal of rheumatology, Vol. 51, Núm. 4, pp. 378-389

  3. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

  4. Quantification of temporomandibular joint space in patients with juvenile idiopathic arthritis assessed by cone beam computerized tomography

    Orthodontics and Craniofacial Research, Vol. 27, Núm. 2, pp. 203-210

2023

  1. Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy

    Pharmaceutics, Vol. 15, Núm. 8

  2. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects

    Frontiers in Endocrinology, Vol. 13

  3. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  4. Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer

    Antioxidants, Vol. 12, Núm. 12

2022

  1. Adipokines as targets in musculoskeletal immune and inflammatory diseases

    Drug Discovery Today, Vol. 27, Núm. 11

  2. Analgesic and antiinflammatory effects of Nigella orientalis L. seeds fixed oil: Pharmacological potentials and molecular mechanisms

    Phytotherapy Research, Vol. 36, Núm. 3, pp. 1372-1385

  3. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

  4. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  5. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  6. Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review

    Pharmaceuticals, Vol. 15, Núm. 12

  7. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1

  8. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. A family-based study to identify genetic biomarkers of fibromyalgia: consideration of patients' subgroups

    Clinical and experimental rheumatology, Vol. 39, Núm. 3, pp. 144-152

  2. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  3. Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib

    Journal of Ethnopharmacology, Vol. 272

  4. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes

    Laboratory Investigation, Vol. 101, Núm. 12, pp. 1550-1560